THE 2-MINUTE RULE FOR IS ABBV-744 EFFECTIVE FOR HEMATOLOGIC CANCERS?

In Segment A, participants will acquire unique doses and schedules of oral ABBV-744 tablet to recognize Secure dosing program. More individuals might be enrolled for the recognized monotherapy dosign program. In Section B, participants will receive oral ruxolitinib and ABBV-744 will be specified as "add-on" therapy. In Phase C, members will receive